New Clostridioides difficile vaccine on the horizon • healthcare-in-europe.com
Emerging Vaccines for Clostridium difficile Infection Treatment
Development of an Effective Nontoxigenic Clostridioides difficile–Based Oral Vaccine against C. difficile Infection | Microbiology Spectrum
In silico designing of vaccine candidate against Clostridium difficile | Scientific Reports
Vaccines | Free Full-Text | Mucosal Vaccination Strategies against Clostridioides difficile Infection
A DNA vaccine targeting TcdA and TcdB induces protective immunity against Clostridium difficile | BMC Infectious Diseases | Full Text
Frontiers | Immunoinformatics Approach Toward the Introduction of a Novel Multi-Epitope Vaccine Against Clostridium difficile
Breakthroughs in the treatment and prevention of Clostridium difficile infection | Nature Reviews Gastroenterology & Hepatology
Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial - The Lancet Infectious Diseases
Clostridium difficile Infection Prevention: Biotherapeutics, Immunologics, and Vaccines - Dale N Gerding - Discovery Medicine
Cytotoxic activity of purified toxins from prevalent C. difficile... | Download Table
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection | NEJM
Vaccines | Free Full-Text | Mucosal Vaccination Strategies against Clostridioides difficile Infection
Percentages of participants who achieved prespecified levels of toxin... | Download Scientific Diagram
Old C. difficile Vaccine Candidate MVX02 | matrivax
Frontiers in antibiotic alternatives for Clostridioides difficile infection
Pfizer's Clostridioides Difficile Vaccine Fails To Prevent C. Difficile Infection
Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes | NEJM
Pfizer's seeks silver lining in failed C. diff vaccine trial | pharmaphorum
C. difficile Vaccine Candidate MVX02 | matrivax
Emerging Vaccines for Clostridium difficile Infection Treatment
Vaccines | Free Full-Text | Mucosal Vaccination Strategies against Clostridioides difficile Infection
C. difficile pipeline vaccines could offer an alternative to antibiotics - Clinical Trials Arena
Frontiers | Host Immune Responses to Clostridioides difficile: Toxins and Beyond
Synthetic Lipoteichoic Acid Glycans Are Potential Vaccine Candidates to Protect from Clostridium difficile Infections - ScienceDirect
JCI Insight - Human C. difficile toxin–specific memory B cell repertoires encode poorly neutralizing antibodies
New Research Tests C. Difficile Vaccine Efficacy - Drexel University College of Medicine
C. diff vaccine trial strikes one blow in bigger bug battle - UCHealth Today
